Isoprinosine (Inosine Pranobex)

Inosine pranobex enhances immune function by stimulating T‑lymphocyte proliferation, increasing interferon‑α production, and boosting natural killer cell activity. This combined cellular and humoral immune activation creates an environment that limits viral replication and assists the body in clearing infections.

The appropriate dose of Isoprinosine is determined by the prescribing clinician based on the specific indication, patient age, weight, renal and hepatic function, and overall clinical condition. No standard dosing regimen is provided here; the prescriber sets the regimen according to current medical guidelines.

Safety data for Isoprinosine during pregnancy and lactation are limited. The product is classified as having an unknown pregnancy category, so it should be used only if the potential benefit justifies the potential risk to the fetus. Breastfeeding mothers should consult their healthcare provider before use.

To order Isoprinosine, submit an enquiry on the product page at gnhindia.com indicating the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials before providing pricing, availability, shipping details and any necessary import documentation.

The primary alternative for many viral infections is a virus‑specific antiviral such as acyclovir for herpes or oseltamivir for influenza. Unlike those agents, Isoprinosine works by broadly stimulating the immune system rather than directly targeting viral enzymes, offering a complementary approach especially when specific antivirals are unavailable or resistance is a concern.

Isoprinosine should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct light, and ensure the container is tightly closed to maintain stability throughout its shelf life.

Isoprinosine is administered orally. The tablets or capsules are taken by mouth with water, usually with or without food as directed by the prescriber. The exact schedule and duration depend on the clinical indication and the treating physician’s recommendation.

Serious risks include severe allergic reactions such as anaphylaxis, hematologic abnormalities like thrombocytopenia or leukopenia, significant liver injury leading to jaundice, and rare cardiac arrhythmias. Patients should seek immediate medical attention if they experience symptoms such as difficulty breathing, unexplained bruising, yellowing of the skin or eyes, or irregular heartbeats.

Isoprinosine is contraindicated in individuals with known hypersensitivity to inosine pranobex or any of its excipients. Caution is advised for patients with severe hepatic or renal impairment, pregnant or nursing women unless clearly indicated, and those receiving live vaccines or potent immunosuppressive therapy, as the drug may interfere with intended effects.